z-logo
open-access-imgOpen Access
Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis‐induced immune deviation and immunosuppression
Author(s) -
Zhao Z.,
Jiang X.,
Kang C.,
Xiao Y.,
Hou C.,
Yu J.,
Wang R.,
Xiao H.,
Zhou T.,
Wen Z.,
Feng J.,
Chen G.,
Ma Y.,
Shen B.,
Li Y.,
Han G.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12401
Subject(s) - immunology , sepsis , immune system , cd80 , inflammation , biology , cd86 , t cell , cd40 , in vitro , cytotoxic t cell , biochemistry
Summary Sepsis is a life‐threatening condition, but the pathophysiological basis and biomarkers for the monitoring of sepsis and as targets for therapy remain to be determined. We have shown previously that T cell immunoglobulin and mucin domain protein 3 ( T im‐3), a negative immune regulator, is involved in the physiopathology of sepsis, but the underlying mechanisms remain unclear. In the present study, we showed that T im‐3 signalling modulated the response patterns of both macrophages and T helper cells in sepsis. Blockade of the T im‐3 pathway exacerbated sepsis‐induced proinflammatory macrophage responses and lymphocyte apoptosis during the early phase of sepsis, and enhanced the shift to anti‐inflammatory responses for both macrophages and T helper cells during the late phase of sepsis. T im‐3 signalling was found to regulate CD 80 and CD 86 expression on macrophages both in vivo and in vitro . Co‐culture of T cells with T im‐3 knock‐down macrophages led to a biased T helper type 2 ( T h2) response, partially explaining how T im‐3 signalling shapes inflammation patterns in vivo . Further studies on this pathway might shed new light on the pathogenesis of sepsis and suggest new approaches for intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom